Low-density lipoprotein cholesterol/apolipoprotein B ratio is superior to apolipoprotein B alone in the diagnosis of coronary artery calcification
Coronary Artery Disease Aug 07, 2021
Chang, Tsui-Yen, Chen, et al. - This study’s findings demonstrate that the low-density lipoprotein cholesterol (LDL-C)/apolipoprotein B (ApoB) ratio is a superior indicator to ApoB in the diagnosis of individuals with coronary artery calcification (CAC). For CAC, it can be conveniently applied to improve the diagnostic ability of ApoB.
The results show that the prevalence of patients with coronary calcification is elevated with the quartile values of ApoB levels and low quartile values of LDL-C/ApoB ratios.
For CAC and severe CAC, the odds ratios were 2.9 [95% confidence interval (CI), 2.2–3.9] and 4.4 (95% CI, 3.3–5.9) among the highest quartile of ApoB compared with the lowest quartile, and 9.5 (95% CI, 8.3–10.9) and 103.0 (95% CI, 56.9–187.8) among the lowest quartile of LDL-C/ApoB ratios compared with the highest quartile.
It was shown that areas under the curve of ApoB and LDL-C/ApoB ratio for the diagnosis of CAC and severe CAC were 0.591 vs 0.679 and 0.618 vs 0.787, respectively.
The data indicated that the LDL-C/ApoB ratio was superior to ApoB in terms of diagnosing patients with CAC and severe CAC.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries